Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis-oriented targets for adjunctive therapy.

Otelo Rigato1, Eliezer Silva, Reinaldo Salomao

  • 1Immunology Laboratory, Division of Infectious Diseases, Universidade Federal de Sao Paulo, CEP 04039-032, Sao Paulo, SP, Brazil.

Endocrine, Metabolic & Immune Disorders Drug Targets
|June 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cleavage and inactivation of poly(ADP-ribose) polymerase in peripheral blood mononuclear cells of patients with acute respiratory distress syndrome.

Respiratory research·2026
Same author

Extracellular vesicles isolated from the plasma of COVID-19 and sepsis patients: characterisation and association with clinical outcomes

Memorias do Instituto Oswaldo Cruz·2026
Same author

Improving the outcomes of sepsis in Brazil: strategies and initiatives.

Critical care science·2025
Same author

IDENTIFYING A SEPSIS SUBPHENOTYPE CHARACTERIZED BY DYSREGULATED LIPOPROTEIN METABOLISM USING A SIMPLIFIED CLINICAL DATA ALGORITHM.

Shock (Augusta, Ga.)·2025
Same author

Characterizing a low-density neutrophil gene signature in acute and chronic infections and its impact on disease severity.

Journal of leukocyte biology·2025
Same author

Circulating extracellular vesicles as potential biomarkers and mediators of acute respiratory distress syndrome in sepsis.

Scientific reports·2025

Despite effective antimicrobial treatments, sepsis mortality remains high. This review explores novel adjunctive sepsis therapies targeting the underlying pathophysiology, offering hope for improved patient survival rates.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pathophysiology

Background:

  • Sepsis outcomes are multifactorial, involving host and microbial factors.
  • Mortality persists despite adequate antimicrobial therapy, necessitating further research.
  • Recent advances in understanding sepsis pathophysiology offer new therapeutic avenues.

Purpose of the Study:

  • To review sepsis pathogenesis.
  • To identify potential targets for adjunctive sepsis therapies.
  • To comment on clinical trials and experimental data for these therapies.

Main Methods:

  • Literature review of published clinical trials.
  • Analysis of experimental data supporting adjunctive therapies.
  • Discussion of pathogenic-oriented therapeutic targets.

Related Experiment Videos

Main Results:

  • Adjunctive sepsis therapies have not yet consistently improved survival rates.
  • Significant progress in understanding sepsis pathophysiology has been made.
  • Identified potential adjunctive therapies include fluid replacement, glucose control, corticosteroids, mechanical ventilation, and activated protein C.

Conclusions:

  • Despite challenges, new effective sepsis treatments are plausible.
  • Targeting sepsis pathophysiology offers promising avenues for adjunctive therapy.
  • Further research and clinical trials are warranted to validate novel interventions.